Fiducient Advisors LLC Has $744,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Fiducient Advisors LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 10.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,414 shares of the healthcare conglomerate’s stock after selling 166 shares during the period. Fiducient Advisors LLC’s holdings in UnitedHealth Group were worth $744,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Bensler LLC boosted its position in UnitedHealth Group by 0.3% during the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after acquiring an additional 19 shares during the last quarter. Texas Capital Bancshares Inc TX boosted its position in UnitedHealth Group by 1.1% during the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after acquiring an additional 19 shares during the last quarter. Tealwood Asset Management Inc. boosted its position in shares of UnitedHealth Group by 0.4% during the 4th quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock worth $2,626,000 after purchasing an additional 19 shares in the last quarter. Atlas Private Wealth Advisors boosted its position in shares of UnitedHealth Group by 1.1% during the 4th quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock worth $923,000 after purchasing an additional 19 shares in the last quarter. Finally, Prentice Wealth Management LLC boosted its position in shares of UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after purchasing an additional 19 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Performance

UNH traded down $5.33 on Tuesday, hitting $483.70. The company’s stock had a trading volume of 3,366,904 shares, compared to its average volume of 4,466,545. The company’s 50 day simple moving average is $484.44 and its 200-day simple moving average is $513.42. The firm has a market cap of $445.04 billion, a P/E ratio of 29.57, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period last year, the firm earned $6.26 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.55%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is 45.97%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Bank of America reaffirmed a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 7th. Piper Sandler raised their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research note on Friday, April 5th. Finally, TD Cowen decreased their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.